nodes	percent_of_prediction	percent_of_DWPC	metapath
Trazodone—ABCB1—lung cancer	0.139	1	CbGaD
Trazodone—ORM1—Gefitinib—lung cancer	0.0733	0.124	CbGbCtD
Trazodone—ORM1—Erlotinib—lung cancer	0.0433	0.0734	CbGbCtD
Trazodone—CYP3A5—Gefitinib—lung cancer	0.0248	0.042	CbGbCtD
Trazodone—CYP3A5—Teniposide—lung cancer	0.024	0.0407	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Paclitaxel—lung cancer	0.0179	0.0303	CbGbCtD
Trazodone—CYP3A7—Paclitaxel—lung cancer	0.0179	0.0303	CbGbCtD
Trazodone—CYP3A7—Irinotecan—lung cancer	0.0176	0.0299	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Irinotecan—lung cancer	0.0176	0.0299	CbGbCtD
Trazodone—ABCB1—Topotecan—lung cancer	0.0176	0.0299	CbGbCtD
Trazodone—ABCB1—Gefitinib—lung cancer	0.0161	0.0273	CbGbCtD
Trazodone—CYP2D6—Gefitinib—lung cancer	0.0152	0.0257	CbGbCtD
Trazodone—CYP3A5—Crizotinib—lung cancer	0.0152	0.0257	CbGbCtD
Trazodone—CYP3A5—Erlotinib—lung cancer	0.0147	0.0248	CbGbCtD
Trazodone—CYP3A5—Paclitaxel—lung cancer	0.0134	0.0227	CbGbCtD
Trazodone—CYP3A5—Irinotecan—lung cancer	0.0132	0.0224	CbGbCtD
Trazodone—CYP3A7—Docetaxel—lung cancer	0.0129	0.0219	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Docetaxel—lung cancer	0.0129	0.0219	CbGbCtD
Trazodone—ABCB1—Vinorelbine—lung cancer	0.0124	0.021	CbGbCtD
Trazodone—CYP2D6—Vinorelbine—lung cancer	0.0117	0.0198	CbGbCtD
Trazodone—CYP3A5—Etoposide—lung cancer	0.0106	0.0179	CbGbCtD
Trazodone—CYP3A4—Topotecan—lung cancer	0.0106	0.0179	CbGbCtD
Trazodone—ABCB1—Crizotinib—lung cancer	0.00988	0.0167	CbGbCtD
Trazodone—CYP3A5—Docetaxel—lung cancer	0.0097	0.0164	CbGbCtD
Trazodone—CYP3A4—Gefitinib—lung cancer	0.00966	0.0164	CbGbCtD
Trazodone—ABCB1—Gemcitabine—lung cancer	0.00966	0.0164	CbGbCtD
Trazodone—ABCB1—Erlotinib—lung cancer	0.00954	0.0161	CbGbCtD
Trazodone—CYP3A4—Teniposide—lung cancer	0.00937	0.0159	CbGbCtD
Trazodone—CYP2D6—Erlotinib—lung cancer	0.00898	0.0152	CbGbCtD
Trazodone—ABCB1—Paclitaxel—lung cancer	0.00873	0.0148	CbGbCtD
Trazodone—ABCB1—Irinotecan—lung cancer	0.00861	0.0146	CbGbCtD
Trazodone—ABCB1—Vinblastine—lung cancer	0.00766	0.013	CbGbCtD
Trazodone—CYP3A4—Vinorelbine—lung cancer	0.00744	0.0126	CbGbCtD
Trazodone—CYP2D6—Vinblastine—lung cancer	0.00721	0.0122	CbGbCtD
Trazodone—ABCB1—Cisplatin—lung cancer	0.00702	0.0119	CbGbCtD
Trazodone—ABCB1—Etoposide—lung cancer	0.0069	0.0117	CbGbCtD
Trazodone—ABCB1—Docetaxel—lung cancer	0.00631	0.0107	CbGbCtD
Trazodone—CYP3A4—Crizotinib—lung cancer	0.00592	0.01	CbGbCtD
Trazodone—CYP3A4—Erlotinib—lung cancer	0.00571	0.00967	CbGbCtD
Trazodone—CYP3A4—Paclitaxel—lung cancer	0.00523	0.00885	CbGbCtD
Trazodone—CYP3A4—Irinotecan—lung cancer	0.00516	0.00874	CbGbCtD
Trazodone—HTR2A—phrenic nerve—lung cancer	0.00501	0.349	CbGeAlD
Trazodone—ABCB1—Doxorubicin—lung cancer	0.0047	0.00797	CbGbCtD
Trazodone—CYP3A4—Vinblastine—lung cancer	0.00459	0.00777	CbGbCtD
Trazodone—ABCB1—Methotrexate—lung cancer	0.00456	0.00772	CbGbCtD
Trazodone—CYP2D6—Doxorubicin—lung cancer	0.00443	0.00751	CbGbCtD
Trazodone—CYP3A4—Etoposide—lung cancer	0.00413	0.007	CbGbCtD
Trazodone—CYP3A4—Docetaxel—lung cancer	0.00378	0.0064	CbGbCtD
Trazodone—CYP3A4—Doxorubicin—lung cancer	0.00282	0.00477	CbGbCtD
Trazodone—HTR2A—pulmonary artery—lung cancer	0.00182	0.127	CbGeAlD
Trazodone—SLC6A4—respiratory system—lung cancer	0.000578	0.0402	CbGeAlD
Trazodone—ORM1—bone marrow—lung cancer	0.000398	0.0277	CbGeAlD
Trazodone—ADRA1A—epithelium—lung cancer	0.000396	0.0275	CbGeAlD
Trazodone—CYP3A5—respiratory system—lung cancer	0.000378	0.0263	CbGeAlD
Trazodone—HRH1—respiratory system—lung cancer	0.000367	0.0255	CbGeAlD
Trazodone—ORM1—lung—lung cancer	0.00036	0.0251	CbGeAlD
Trazodone—SLC6A4—lung—lung cancer	0.000307	0.0214	CbGeAlD
Trazodone—HRH1—epithelium—lung cancer	0.000306	0.0213	CbGeAlD
Trazodone—HTR2A—respiratory system—lung cancer	0.000306	0.0213	CbGeAlD
Trazodone—HTR2B—lung—lung cancer	0.000304	0.0212	CbGeAlD
Trazodone—ADRA2A—bronchus—lung cancer	0.000296	0.0206	CbGeAlD
Trazodone—HRH1—trachea—lung cancer	0.000271	0.0188	CbGeAlD
Trazodone—ADRA2A—trachea—lung cancer	0.000266	0.0185	CbGeAlD
Trazodone—HTR2A—epithelium—lung cancer	0.000256	0.0178	CbGeAlD
Trazodone—ADRA2A—cardiac atrium—lung cancer	0.00025	0.0174	CbGeAlD
Trazodone—ORM1—lymph node—lung cancer	0.000247	0.0171	CbGeAlD
Trazodone—HTR2A—trachea—lung cancer	0.000226	0.0157	CbGeAlD
Trazodone—HTR2B—lymph node—lung cancer	0.000208	0.0145	CbGeAlD
Trazodone—ABCB1—respiratory system—lung cancer	0.000201	0.0139	CbGeAlD
Trazodone—CYP3A5—lung—lung cancer	0.000201	0.0139	CbGeAlD
Trazodone—HRH1—lung—lung cancer	0.000195	0.0135	CbGeAlD
Trazodone—ADRA2A—lung—lung cancer	0.000191	0.0133	CbGeAlD
Trazodone—ABCB1—epithelium—lung cancer	0.000168	0.0117	CbGeAlD
Trazodone—HTR2A—lung—lung cancer	0.000163	0.0113	CbGeAlD
Trazodone—Fluphenazine—CYP2E1—lung cancer	0.00015	0.128	CrCbGaD
Trazodone—ABCB1—trachea—lung cancer	0.000148	0.0103	CbGeAlD
Trazodone—Clozapine—CYP2A6—lung cancer	0.000141	0.12	CrCbGaD
Trazodone—HRH1—lymph node—lung cancer	0.000133	0.00926	CbGeAlD
Trazodone—ADRA2A—lymph node—lung cancer	0.000131	0.00909	CbGeAlD
Trazodone—Domperidone—ABCB1—lung cancer	0.000126	0.108	CrCbGaD
Trazodone—ABCB1—bone marrow—lung cancer	0.000118	0.00818	CbGeAlD
Trazodone—ABCB1—lung—lung cancer	0.000107	0.00741	CbGeAlD
Trazodone—Nefazodone—ABCB1—lung cancer	0.000105	0.0897	CrCbGaD
Trazodone—Oedema—Paclitaxel—lung cancer	0.000103	0.000581	CcSEcCtD
Trazodone—Paraesthesia—Cisplatin—lung cancer	0.000103	0.000581	CcSEcCtD
Trazodone—Tachycardia—Etoposide—lung cancer	0.000102	0.000578	CcSEcCtD
Trazodone—Dyspnoea—Cisplatin—lung cancer	0.000102	0.000577	CcSEcCtD
Trazodone—Erectile dysfunction—Methotrexate—lung cancer	0.000102	0.000575	CcSEcCtD
Trazodone—Hyperhidrosis—Etoposide—lung cancer	0.000101	0.000573	CcSEcCtD
Trazodone—Feeling abnormal—Gemcitabine—lung cancer	0.000101	0.000572	CcSEcCtD
Trazodone—Shock—Paclitaxel—lung cancer	0.000101	0.000572	CcSEcCtD
Trazodone—Dizziness—Vinorelbine—lung cancer	0.000101	0.000571	CcSEcCtD
Trazodone—Orthostatic hypotension—Doxorubicin—lung cancer	0.000101	0.000571	CcSEcCtD
Trazodone—Photosensitivity reaction—Methotrexate—lung cancer	0.000101	0.00057	CcSEcCtD
Trazodone—Tachycardia—Paclitaxel—lung cancer	0.0001	0.000567	CcSEcCtD
Trazodone—Clozapine—CYP2E1—lung cancer	0.0001	0.0855	CrCbGaD
Trazodone—Anorexia—Etoposide—lung cancer	9.98e-05	0.000565	CcSEcCtD
Trazodone—Abdominal pain—Irinotecan—lung cancer	9.95e-05	0.000563	CcSEcCtD
Trazodone—Body temperature increased—Irinotecan—lung cancer	9.95e-05	0.000563	CcSEcCtD
Trazodone—Decreased appetite—Cisplatin—lung cancer	9.94e-05	0.000562	CcSEcCtD
Trazodone—Hyperhidrosis—Paclitaxel—lung cancer	9.93e-05	0.000562	CcSEcCtD
Trazodone—Clozapine—CYP1A1—lung cancer	9.86e-05	0.0843	CrCbGaD
Trazodone—Anaemia—Docetaxel—lung cancer	9.86e-05	0.000558	CcSEcCtD
Trazodone—Drowsiness—Methotrexate—lung cancer	9.83e-05	0.000556	CcSEcCtD
Trazodone—Anorexia—Paclitaxel—lung cancer	9.79e-05	0.000554	CcSEcCtD
Trazodone—Hypotension—Etoposide—lung cancer	9.78e-05	0.000554	CcSEcCtD
Trazodone—Pain—Cisplatin—lung cancer	9.77e-05	0.000553	CcSEcCtD
Trazodone—Aripiprazole—ABCB1—lung cancer	9.75e-05	0.0834	CrCbGaD
Trazodone—Vomiting—Vinorelbine—lung cancer	9.71e-05	0.000549	CcSEcCtD
Trazodone—Body temperature increased—Gemcitabine—lung cancer	9.69e-05	0.000549	CcSEcCtD
Trazodone—Thioproperazine—ALB—lung cancer	9.68e-05	0.0828	CrCbGaD
Trazodone—Rash—Vinorelbine—lung cancer	9.62e-05	0.000545	CcSEcCtD
Trazodone—Dermatitis—Vinorelbine—lung cancer	9.62e-05	0.000544	CcSEcCtD
Trazodone—Hypotension—Paclitaxel—lung cancer	9.59e-05	0.000543	CcSEcCtD
Trazodone—Headache—Vinorelbine—lung cancer	9.56e-05	0.000541	CcSEcCtD
Trazodone—Syncope—Docetaxel—lung cancer	9.56e-05	0.000541	CcSEcCtD
Trazodone—Sweating—Methotrexate—lung cancer	9.43e-05	0.000533	CcSEcCtD
Trazodone—Palpitations—Docetaxel—lung cancer	9.42e-05	0.000533	CcSEcCtD
Trazodone—Feeling abnormal—Cisplatin—lung cancer	9.42e-05	0.000533	CcSEcCtD
Trazodone—Paraesthesia—Etoposide—lung cancer	9.4e-05	0.000532	CcSEcCtD
Trazodone—Haematuria—Methotrexate—lung cancer	9.38e-05	0.000531	CcSEcCtD
Trazodone—Loss of consciousness—Docetaxel—lung cancer	9.37e-05	0.00053	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Paclitaxel—lung cancer	9.35e-05	0.000529	CcSEcCtD
Trazodone—Dyspnoea—Etoposide—lung cancer	9.34e-05	0.000528	CcSEcCtD
Trazodone—Somnolence—Etoposide—lung cancer	9.31e-05	0.000527	CcSEcCtD
Trazodone—Insomnia—Paclitaxel—lung cancer	9.29e-05	0.000525	CcSEcCtD
Trazodone—Hypersensitivity—Irinotecan—lung cancer	9.27e-05	0.000525	CcSEcCtD
Trazodone—Paraesthesia—Paclitaxel—lung cancer	9.22e-05	0.000522	CcSEcCtD
Trazodone—Hypertension—Docetaxel—lung cancer	9.21e-05	0.000521	CcSEcCtD
Trazodone—Dyspnoea—Paclitaxel—lung cancer	9.15e-05	0.000518	CcSEcCtD
Trazodone—Somnolence—Paclitaxel—lung cancer	9.13e-05	0.000516	CcSEcCtD
Trazodone—Decreased appetite—Etoposide—lung cancer	9.1e-05	0.000515	CcSEcCtD
Trazodone—Arthralgia—Docetaxel—lung cancer	9.08e-05	0.000514	CcSEcCtD
Trazodone—Chest pain—Docetaxel—lung cancer	9.08e-05	0.000514	CcSEcCtD
Trazodone—Myalgia—Docetaxel—lung cancer	9.08e-05	0.000514	CcSEcCtD
Trazodone—Nausea—Vinorelbine—lung cancer	9.07e-05	0.000513	CcSEcCtD
Trazodone—Body temperature increased—Cisplatin—lung cancer	9.04e-05	0.000511	CcSEcCtD
Trazodone—Asthenia—Irinotecan—lung cancer	9.03e-05	0.000511	CcSEcCtD
Trazodone—Fatigue—Etoposide—lung cancer	9.03e-05	0.000511	CcSEcCtD
Trazodone—Pain—Etoposide—lung cancer	8.95e-05	0.000507	CcSEcCtD
Trazodone—Constipation—Etoposide—lung cancer	8.95e-05	0.000507	CcSEcCtD
Trazodone—Decreased appetite—Paclitaxel—lung cancer	8.93e-05	0.000505	CcSEcCtD
Trazodone—Dry mouth—Docetaxel—lung cancer	8.88e-05	0.000502	CcSEcCtD
Trazodone—Fatigue—Paclitaxel—lung cancer	8.85e-05	0.000501	CcSEcCtD
Trazodone—Pollakiuria—Doxorubicin—lung cancer	8.82e-05	0.000499	CcSEcCtD
Trazodone—Asthenia—Gemcitabine—lung cancer	8.8e-05	0.000498	CcSEcCtD
Trazodone—Pain—Paclitaxel—lung cancer	8.78e-05	0.000497	CcSEcCtD
Trazodone—Constipation—Paclitaxel—lung cancer	8.78e-05	0.000497	CcSEcCtD
Trazodone—Confusional state—Docetaxel—lung cancer	8.77e-05	0.000496	CcSEcCtD
Trazodone—Photosensitivity reaction—Doxorubicin—lung cancer	8.72e-05	0.000493	CcSEcCtD
Trazodone—Oedema—Docetaxel—lung cancer	8.7e-05	0.000492	CcSEcCtD
Trazodone—Weight increased—Doxorubicin—lung cancer	8.69e-05	0.000492	CcSEcCtD
Trazodone—Pruritus—Gemcitabine—lung cancer	8.68e-05	0.000491	CcSEcCtD
Trazodone—Weight decreased—Doxorubicin—lung cancer	8.64e-05	0.000489	CcSEcCtD
Trazodone—Feeling abnormal—Etoposide—lung cancer	8.63e-05	0.000488	CcSEcCtD
Trazodone—Diarrhoea—Irinotecan—lung cancer	8.61e-05	0.000487	CcSEcCtD
Trazodone—Gastrointestinal pain—Etoposide—lung cancer	8.56e-05	0.000484	CcSEcCtD
Trazodone—Shock—Docetaxel—lung cancer	8.56e-05	0.000484	CcSEcCtD
Trazodone—Drowsiness—Doxorubicin—lung cancer	8.52e-05	0.000482	CcSEcCtD
Trazodone—Visual impairment—Methotrexate—lung cancer	8.51e-05	0.000481	CcSEcCtD
Trazodone—Tachycardia—Docetaxel—lung cancer	8.49e-05	0.000481	CcSEcCtD
Trazodone—Feeling abnormal—Paclitaxel—lung cancer	8.46e-05	0.000479	CcSEcCtD
Trazodone—Hypersensitivity—Cisplatin—lung cancer	8.42e-05	0.000476	CcSEcCtD
Trazodone—Gastrointestinal pain—Paclitaxel—lung cancer	8.4e-05	0.000475	CcSEcCtD
Trazodone—Diarrhoea—Gemcitabine—lung cancer	8.39e-05	0.000475	CcSEcCtD
Trazodone—Dizziness—Irinotecan—lung cancer	8.32e-05	0.000471	CcSEcCtD
Trazodone—Urticaria—Etoposide—lung cancer	8.32e-05	0.000471	CcSEcCtD
Trazodone—Jaundice—Doxorubicin—lung cancer	8.3e-05	0.00047	CcSEcCtD
Trazodone—Anorexia—Docetaxel—lung cancer	8.3e-05	0.000469	CcSEcCtD
Trazodone—Abdominal pain—Etoposide—lung cancer	8.28e-05	0.000468	CcSEcCtD
Trazodone—Body temperature increased—Etoposide—lung cancer	8.28e-05	0.000468	CcSEcCtD
Trazodone—Tinnitus—Methotrexate—lung cancer	8.23e-05	0.000466	CcSEcCtD
Trazodone—Asthenia—Cisplatin—lung cancer	8.2e-05	0.000464	CcSEcCtD
Trazodone—Sweating—Doxorubicin—lung cancer	8.16e-05	0.000462	CcSEcCtD
Trazodone—Urticaria—Paclitaxel—lung cancer	8.16e-05	0.000462	CcSEcCtD
Trazodone—Hypotension—Docetaxel—lung cancer	8.13e-05	0.00046	CcSEcCtD
Trazodone—Haematuria—Doxorubicin—lung cancer	8.12e-05	0.000459	CcSEcCtD
Trazodone—Abdominal pain—Paclitaxel—lung cancer	8.12e-05	0.000459	CcSEcCtD
Trazodone—Body temperature increased—Paclitaxel—lung cancer	8.12e-05	0.000459	CcSEcCtD
Trazodone—Vomiting—Irinotecan—lung cancer	8e-05	0.000453	CcSEcCtD
Trazodone—Rash—Irinotecan—lung cancer	7.94e-05	0.000449	CcSEcCtD
Trazodone—Dermatitis—Irinotecan—lung cancer	7.93e-05	0.000449	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Docetaxel—lung cancer	7.93e-05	0.000449	CcSEcCtD
Trazodone—Chills—Methotrexate—lung cancer	7.92e-05	0.000448	CcSEcCtD
Trazodone—Headache—Irinotecan—lung cancer	7.89e-05	0.000446	CcSEcCtD
Trazodone—Insomnia—Docetaxel—lung cancer	7.87e-05	0.000445	CcSEcCtD
Trazodone—Fluphenazine—ABCB1—lung cancer	7.86e-05	0.0672	CrCbGaD
Trazodone—Diarrhoea—Cisplatin—lung cancer	7.82e-05	0.000443	CcSEcCtD
Trazodone—Paraesthesia—Docetaxel—lung cancer	7.81e-05	0.000442	CcSEcCtD
Trazodone—Alopecia—Methotrexate—lung cancer	7.8e-05	0.000441	CcSEcCtD
Trazodone—Vomiting—Gemcitabine—lung cancer	7.8e-05	0.000441	CcSEcCtD
Trazodone—Bradycardia—Doxorubicin—lung cancer	7.78e-05	0.00044	CcSEcCtD
Trazodone—Dyspnoea—Docetaxel—lung cancer	7.76e-05	0.000439	CcSEcCtD
Trazodone—Somnolence—Docetaxel—lung cancer	7.74e-05	0.000438	CcSEcCtD
Trazodone—Rash—Gemcitabine—lung cancer	7.73e-05	0.000437	CcSEcCtD
Trazodone—Dermatitis—Gemcitabine—lung cancer	7.72e-05	0.000437	CcSEcCtD
Trazodone—Hypersensitivity—Etoposide—lung cancer	7.71e-05	0.000437	CcSEcCtD
Trazodone—Headache—Gemcitabine—lung cancer	7.68e-05	0.000435	CcSEcCtD
Trazodone—Hypoaesthesia—Doxorubicin—lung cancer	7.61e-05	0.00043	CcSEcCtD
Trazodone—Decreased appetite—Docetaxel—lung cancer	7.56e-05	0.000428	CcSEcCtD
Trazodone—Hypersensitivity—Paclitaxel—lung cancer	7.56e-05	0.000428	CcSEcCtD
Trazodone—Dysgeusia—Methotrexate—lung cancer	7.53e-05	0.000426	CcSEcCtD
Trazodone—Asthenia—Etoposide—lung cancer	7.51e-05	0.000425	CcSEcCtD
Trazodone—Fatigue—Docetaxel—lung cancer	7.5e-05	0.000425	CcSEcCtD
Trazodone—Nausea—Irinotecan—lung cancer	7.48e-05	0.000423	CcSEcCtD
Trazodone—Constipation—Docetaxel—lung cancer	7.44e-05	0.000421	CcSEcCtD
Trazodone—Pain—Docetaxel—lung cancer	7.44e-05	0.000421	CcSEcCtD
Trazodone—Back pain—Methotrexate—lung cancer	7.43e-05	0.000421	CcSEcCtD
Trazodone—Pruritus—Etoposide—lung cancer	7.41e-05	0.000419	CcSEcCtD
Trazodone—Visual impairment—Doxorubicin—lung cancer	7.37e-05	0.000417	CcSEcCtD
Trazodone—Asthenia—Paclitaxel—lung cancer	7.37e-05	0.000417	CcSEcCtD
Trazodone—ABCB1—lymph node—lung cancer	7.28e-05	0.00507	CbGeAlD
Trazodone—Nausea—Gemcitabine—lung cancer	7.28e-05	0.000412	CcSEcCtD
Trazodone—Vomiting—Cisplatin—lung cancer	7.27e-05	0.000411	CcSEcCtD
Trazodone—Pruritus—Paclitaxel—lung cancer	7.26e-05	0.000411	CcSEcCtD
Trazodone—Vision blurred—Methotrexate—lung cancer	7.24e-05	0.00041	CcSEcCtD
Trazodone—Rash—Cisplatin—lung cancer	7.21e-05	0.000408	CcSEcCtD
Trazodone—Dermatitis—Cisplatin—lung cancer	7.2e-05	0.000407	CcSEcCtD
Trazodone—Feeling abnormal—Docetaxel—lung cancer	7.17e-05	0.000406	CcSEcCtD
Trazodone—Diarrhoea—Etoposide—lung cancer	7.16e-05	0.000405	CcSEcCtD
Trazodone—Ill-defined disorder—Methotrexate—lung cancer	7.13e-05	0.000403	CcSEcCtD
Trazodone—Tinnitus—Doxorubicin—lung cancer	7.13e-05	0.000403	CcSEcCtD
Trazodone—Gastrointestinal pain—Docetaxel—lung cancer	7.12e-05	0.000403	CcSEcCtD
Trazodone—Anaemia—Methotrexate—lung cancer	7.1e-05	0.000402	CcSEcCtD
Trazodone—Flushing—Doxorubicin—lung cancer	7.09e-05	0.000401	CcSEcCtD
Trazodone—Diarrhoea—Paclitaxel—lung cancer	7.02e-05	0.000397	CcSEcCtD
Trazodone—Malaise—Methotrexate—lung cancer	6.93e-05	0.000392	CcSEcCtD
Trazodone—Dizziness—Etoposide—lung cancer	6.92e-05	0.000392	CcSEcCtD
Trazodone—Vertigo—Methotrexate—lung cancer	6.9e-05	0.000391	CcSEcCtD
Trazodone—Abdominal pain—Docetaxel—lung cancer	6.88e-05	0.000389	CcSEcCtD
Trazodone—Body temperature increased—Docetaxel—lung cancer	6.88e-05	0.000389	CcSEcCtD
Trazodone—Chills—Doxorubicin—lung cancer	6.86e-05	0.000388	CcSEcCtD
Trazodone—Arrhythmia—Doxorubicin—lung cancer	6.83e-05	0.000386	CcSEcCtD
Trazodone—Dizziness—Paclitaxel—lung cancer	6.79e-05	0.000384	CcSEcCtD
Trazodone—Nausea—Cisplatin—lung cancer	6.79e-05	0.000384	CcSEcCtD
Trazodone—Alopecia—Doxorubicin—lung cancer	6.76e-05	0.000382	CcSEcCtD
Trazodone—Vomiting—Etoposide—lung cancer	6.66e-05	0.000377	CcSEcCtD
Trazodone—Rash—Etoposide—lung cancer	6.6e-05	0.000374	CcSEcCtD
Trazodone—Dermatitis—Etoposide—lung cancer	6.6e-05	0.000373	CcSEcCtD
Trazodone—Headache—Etoposide—lung cancer	6.56e-05	0.000371	CcSEcCtD
Trazodone—Flatulence—Doxorubicin—lung cancer	6.56e-05	0.000371	CcSEcCtD
Trazodone—Myalgia—Methotrexate—lung cancer	6.54e-05	0.00037	CcSEcCtD
Trazodone—Arthralgia—Methotrexate—lung cancer	6.54e-05	0.00037	CcSEcCtD
Trazodone—Chest pain—Methotrexate—lung cancer	6.54e-05	0.00037	CcSEcCtD
Trazodone—Tension—Doxorubicin—lung cancer	6.53e-05	0.000369	CcSEcCtD
Trazodone—Vomiting—Paclitaxel—lung cancer	6.53e-05	0.000369	CcSEcCtD
Trazodone—Dysgeusia—Doxorubicin—lung cancer	6.52e-05	0.000369	CcSEcCtD
Trazodone—Rash—Paclitaxel—lung cancer	6.47e-05	0.000366	CcSEcCtD
Trazodone—Dermatitis—Paclitaxel—lung cancer	6.47e-05	0.000366	CcSEcCtD
Trazodone—Discomfort—Methotrexate—lung cancer	6.46e-05	0.000366	CcSEcCtD
Trazodone—Nervousness—Doxorubicin—lung cancer	6.46e-05	0.000366	CcSEcCtD
Trazodone—Back pain—Doxorubicin—lung cancer	6.44e-05	0.000364	CcSEcCtD
Trazodone—Headache—Paclitaxel—lung cancer	6.43e-05	0.000364	CcSEcCtD
Trazodone—Hypersensitivity—Docetaxel—lung cancer	6.41e-05	0.000363	CcSEcCtD
Trazodone—Confusional state—Methotrexate—lung cancer	6.32e-05	0.000358	CcSEcCtD
Trazodone—Trifluoperazine—ABCB1—lung cancer	6.28e-05	0.0537	CrCbGaD
Trazodone—Vision blurred—Doxorubicin—lung cancer	6.27e-05	0.000355	CcSEcCtD
Trazodone—Asthenia—Docetaxel—lung cancer	6.24e-05	0.000353	CcSEcCtD
Trazodone—Nausea—Etoposide—lung cancer	6.22e-05	0.000352	CcSEcCtD
Trazodone—Ill-defined disorder—Doxorubicin—lung cancer	6.17e-05	0.000349	CcSEcCtD
Trazodone—Pruritus—Docetaxel—lung cancer	6.16e-05	0.000348	CcSEcCtD
Trazodone—Anaemia—Doxorubicin—lung cancer	6.15e-05	0.000348	CcSEcCtD
Trazodone—Agitation—Doxorubicin—lung cancer	6.12e-05	0.000346	CcSEcCtD
Trazodone—Nausea—Paclitaxel—lung cancer	6.1e-05	0.000345	CcSEcCtD
Trazodone—Quetiapine—ABCB1—lung cancer	6.09e-05	0.0521	CrCbGaD
Trazodone—Hyperhidrosis—Methotrexate—lung cancer	6.06e-05	0.000343	CcSEcCtD
Trazodone—Malaise—Doxorubicin—lung cancer	6e-05	0.00034	CcSEcCtD
Trazodone—Vertigo—Doxorubicin—lung cancer	5.98e-05	0.000338	CcSEcCtD
Trazodone—Anorexia—Methotrexate—lung cancer	5.98e-05	0.000338	CcSEcCtD
Trazodone—Syncope—Doxorubicin—lung cancer	5.97e-05	0.000338	CcSEcCtD
Trazodone—Diarrhoea—Docetaxel—lung cancer	5.95e-05	0.000337	CcSEcCtD
Trazodone—Palpitations—Doxorubicin—lung cancer	5.88e-05	0.000333	CcSEcCtD
Trazodone—Hypotension—Methotrexate—lung cancer	5.86e-05	0.000332	CcSEcCtD
Trazodone—Loss of consciousness—Doxorubicin—lung cancer	5.85e-05	0.000331	CcSEcCtD
Trazodone—Dizziness—Docetaxel—lung cancer	5.75e-05	0.000326	CcSEcCtD
Trazodone—Hypertension—Doxorubicin—lung cancer	5.75e-05	0.000325	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Methotrexate—lung cancer	5.71e-05	0.000323	CcSEcCtD
Trazodone—Insomnia—Methotrexate—lung cancer	5.67e-05	0.000321	CcSEcCtD
Trazodone—Myalgia—Doxorubicin—lung cancer	5.67e-05	0.000321	CcSEcCtD
Trazodone—Chest pain—Doxorubicin—lung cancer	5.67e-05	0.000321	CcSEcCtD
Trazodone—Arthralgia—Doxorubicin—lung cancer	5.67e-05	0.000321	CcSEcCtD
Trazodone—Anxiety—Doxorubicin—lung cancer	5.65e-05	0.000319	CcSEcCtD
Trazodone—Paraesthesia—Methotrexate—lung cancer	5.63e-05	0.000319	CcSEcCtD
Trazodone—Discomfort—Doxorubicin—lung cancer	5.6e-05	0.000317	CcSEcCtD
Trazodone—Dyspnoea—Methotrexate—lung cancer	5.59e-05	0.000316	CcSEcCtD
Trazodone—Somnolence—Methotrexate—lung cancer	5.58e-05	0.000316	CcSEcCtD
Trazodone—Dry mouth—Doxorubicin—lung cancer	5.54e-05	0.000314	CcSEcCtD
Trazodone—Vomiting—Docetaxel—lung cancer	5.53e-05	0.000313	CcSEcCtD
Trazodone—Rash—Docetaxel—lung cancer	5.49e-05	0.00031	CcSEcCtD
Trazodone—Dermatitis—Docetaxel—lung cancer	5.48e-05	0.00031	CcSEcCtD
Trazodone—Confusional state—Doxorubicin—lung cancer	5.48e-05	0.00031	CcSEcCtD
Trazodone—Decreased appetite—Methotrexate—lung cancer	5.45e-05	0.000309	CcSEcCtD
Trazodone—Headache—Docetaxel—lung cancer	5.45e-05	0.000308	CcSEcCtD
Trazodone—Oedema—Doxorubicin—lung cancer	5.43e-05	0.000307	CcSEcCtD
Trazodone—Fatigue—Methotrexate—lung cancer	5.41e-05	0.000306	CcSEcCtD
Trazodone—Pain—Methotrexate—lung cancer	5.36e-05	0.000303	CcSEcCtD
Trazodone—Shock—Doxorubicin—lung cancer	5.34e-05	0.000302	CcSEcCtD
Trazodone—Tachycardia—Doxorubicin—lung cancer	5.3e-05	0.0003	CcSEcCtD
Trazodone—Hyperhidrosis—Doxorubicin—lung cancer	5.25e-05	0.000297	CcSEcCtD
Trazodone—Clozapine—ABCB1—lung cancer	5.24e-05	0.0448	CrCbGaD
Trazodone—Anorexia—Doxorubicin—lung cancer	5.18e-05	0.000293	CcSEcCtD
Trazodone—Nausea—Docetaxel—lung cancer	5.17e-05	0.000292	CcSEcCtD
Trazodone—Feeling abnormal—Methotrexate—lung cancer	5.17e-05	0.000292	CcSEcCtD
Trazodone—Gastrointestinal pain—Methotrexate—lung cancer	5.13e-05	0.00029	CcSEcCtD
Trazodone—Hypotension—Doxorubicin—lung cancer	5.07e-05	0.000287	CcSEcCtD
Trazodone—Urticaria—Methotrexate—lung cancer	4.98e-05	0.000282	CcSEcCtD
Trazodone—Body temperature increased—Methotrexate—lung cancer	4.96e-05	0.000281	CcSEcCtD
Trazodone—Abdominal pain—Methotrexate—lung cancer	4.96e-05	0.000281	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Doxorubicin—lung cancer	4.95e-05	0.00028	CcSEcCtD
Trazodone—Insomnia—Doxorubicin—lung cancer	4.91e-05	0.000278	CcSEcCtD
Trazodone—Paraesthesia—Doxorubicin—lung cancer	4.88e-05	0.000276	CcSEcCtD
Trazodone—Dyspnoea—Doxorubicin—lung cancer	4.84e-05	0.000274	CcSEcCtD
Trazodone—Somnolence—Doxorubicin—lung cancer	4.83e-05	0.000273	CcSEcCtD
Trazodone—Decreased appetite—Doxorubicin—lung cancer	4.72e-05	0.000267	CcSEcCtD
Trazodone—Fatigue—Doxorubicin—lung cancer	4.68e-05	0.000265	CcSEcCtD
Trazodone—Pain—Doxorubicin—lung cancer	4.64e-05	0.000263	CcSEcCtD
Trazodone—Constipation—Doxorubicin—lung cancer	4.64e-05	0.000263	CcSEcCtD
Trazodone—Hypersensitivity—Methotrexate—lung cancer	4.62e-05	0.000261	CcSEcCtD
Trazodone—Asthenia—Methotrexate—lung cancer	4.5e-05	0.000255	CcSEcCtD
Trazodone—Feeling abnormal—Doxorubicin—lung cancer	4.48e-05	0.000253	CcSEcCtD
Trazodone—Gastrointestinal pain—Doxorubicin—lung cancer	4.44e-05	0.000251	CcSEcCtD
Trazodone—Pruritus—Methotrexate—lung cancer	4.44e-05	0.000251	CcSEcCtD
Trazodone—Urticaria—Doxorubicin—lung cancer	4.31e-05	0.000244	CcSEcCtD
Trazodone—Abdominal pain—Doxorubicin—lung cancer	4.29e-05	0.000243	CcSEcCtD
Trazodone—Body temperature increased—Doxorubicin—lung cancer	4.29e-05	0.000243	CcSEcCtD
Trazodone—Diarrhoea—Methotrexate—lung cancer	4.29e-05	0.000243	CcSEcCtD
Trazodone—Dizziness—Methotrexate—lung cancer	4.15e-05	0.000235	CcSEcCtD
Trazodone—Hypersensitivity—Doxorubicin—lung cancer	4e-05	0.000226	CcSEcCtD
Trazodone—Vomiting—Methotrexate—lung cancer	3.99e-05	0.000226	CcSEcCtD
Trazodone—Rash—Methotrexate—lung cancer	3.95e-05	0.000224	CcSEcCtD
Trazodone—Dermatitis—Methotrexate—lung cancer	3.95e-05	0.000224	CcSEcCtD
Trazodone—Headache—Methotrexate—lung cancer	3.93e-05	0.000222	CcSEcCtD
Trazodone—Asthenia—Doxorubicin—lung cancer	3.9e-05	0.00022	CcSEcCtD
Trazodone—Pruritus—Doxorubicin—lung cancer	3.84e-05	0.000217	CcSEcCtD
Trazodone—Nausea—Methotrexate—lung cancer	3.73e-05	0.000211	CcSEcCtD
Trazodone—Diarrhoea—Doxorubicin—lung cancer	3.72e-05	0.00021	CcSEcCtD
Trazodone—Dizziness—Doxorubicin—lung cancer	3.59e-05	0.000203	CcSEcCtD
Trazodone—Vomiting—Doxorubicin—lung cancer	3.45e-05	0.000195	CcSEcCtD
Trazodone—Rash—Doxorubicin—lung cancer	3.42e-05	0.000194	CcSEcCtD
Trazodone—Dermatitis—Doxorubicin—lung cancer	3.42e-05	0.000194	CcSEcCtD
Trazodone—Headache—Doxorubicin—lung cancer	3.4e-05	0.000193	CcSEcCtD
Trazodone—Nausea—Doxorubicin—lung cancer	3.23e-05	0.000183	CcSEcCtD
Trazodone—ADRA2A—Metabolism—PIK3CB—lung cancer	4.04e-06	5.16e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—EGFR—lung cancer	4.01e-06	5.13e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—PTGS2—lung cancer	4e-06	5.11e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—APOA1—lung cancer	3.99e-06	5.1e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CYP2E1—lung cancer	3.99e-06	5.1e-05	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—AKT1—lung cancer	3.99e-06	5.1e-05	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—AKT1—lung cancer	3.97e-06	5.07e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CASP3—lung cancer	3.95e-06	5.05e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—IL2—lung cancer	3.94e-06	5.04e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—NQO1—lung cancer	3.94e-06	5.04e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CASP3—lung cancer	3.93e-06	5.02e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—IL6—lung cancer	3.92e-06	5.02e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—IL2—lung cancer	3.92e-06	5.02e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—MAPK3—lung cancer	3.91e-06	5e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—IL6—lung cancer	3.9e-06	4.99e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MAP2K1—lung cancer	3.9e-06	4.98e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PIK3CD—lung cancer	3.87e-06	4.95e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CCND1—lung cancer	3.84e-06	4.92e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—JUN—lung cancer	3.84e-06	4.91e-05	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—PIK3CA—lung cancer	3.84e-06	4.9e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—PIK3CA—lung cancer	3.83e-06	4.9e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CCND1—lung cancer	3.82e-06	4.89e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—PIK3CA—lung cancer	3.82e-06	4.88e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—JUN—lung cancer	3.82e-06	4.88e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—MDM2—lung cancer	3.81e-06	4.88e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—MDM2—lung cancer	3.8e-06	4.86e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—MYC—lung cancer	3.8e-06	4.86e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—RAF1—lung cancer	3.8e-06	4.86e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—RAF1—lung cancer	3.79e-06	4.85e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—KRAS—lung cancer	3.79e-06	4.85e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—APOA1—lung cancer	3.76e-06	4.81e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—ERBB2—lung cancer	3.76e-06	4.81e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—ERBB2—lung cancer	3.75e-06	4.8e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—PIK3CA—lung cancer	3.75e-06	4.79e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—MDM2—lung cancer	3.73e-06	4.77e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—MMP9—lung cancer	3.73e-06	4.77e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—RAF1—lung cancer	3.72e-06	4.76e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—EGFR—lung cancer	3.72e-06	4.76e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CDKN1A—lung cancer	3.72e-06	4.76e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—MMP9—lung cancer	3.71e-06	4.75e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—PTEN—lung cancer	3.71e-06	4.74e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PIK3CB—lung cancer	3.71e-06	4.74e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—MTOR—lung cancer	3.71e-06	4.74e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PIK3CB—lung cancer	3.7e-06	4.73e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—MTOR—lung cancer	3.7e-06	4.73e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CDKN1A—lung cancer	3.7e-06	4.73e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PIK3CB—lung cancer	3.7e-06	4.73e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—PTEN—lung cancer	3.69e-06	4.72e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—ERBB2—lung cancer	3.68e-06	4.71e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PTGS2—lung cancer	3.67e-06	4.69e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PIK3CG—lung cancer	3.64e-06	4.66e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PIK3CB—lung cancer	3.63e-06	4.64e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—MTOR—lung cancer	3.63e-06	4.64e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—AKT1—lung cancer	3.62e-06	4.63e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—AKT1—lung cancer	3.6e-06	4.6e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CXCL8—lung cancer	3.57e-06	4.56e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CXCL8—lung cancer	3.56e-06	4.55e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—STK11—lung cancer	3.55e-06	4.54e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—HRAS—lung cancer	3.54e-06	4.53e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—EP300—lung cancer	3.54e-06	4.52e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—HRAS—lung cancer	3.53e-06	4.52e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—EP300—lung cancer	3.52e-06	4.5e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—KRAS—lung cancer	3.51e-06	4.49e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CXCL8—lung cancer	3.49e-06	4.46e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—PTEN—lung cancer	3.49e-06	4.46e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—PIK3CA—lung cancer	3.48e-06	4.45e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MDM2—lung cancer	3.47e-06	4.44e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—HRAS—lung cancer	3.47e-06	4.43e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—POMC—lung cancer	3.47e-06	4.43e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—RAF1—lung cancer	3.46e-06	4.42e-05	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—AKT1—lung cancer	3.44e-06	4.4e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—SRC—lung cancer	3.44e-06	4.4e-05	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—AKT1—lung cancer	3.44e-06	4.39e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PIK3CG—lung cancer	3.43e-06	4.39e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—SRC—lung cancer	3.42e-06	4.38e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—ERBB2—lung cancer	3.42e-06	4.37e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CASP3—lung cancer	3.41e-06	4.36e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—IL2—lung cancer	3.41e-06	4.36e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CASP3—lung cancer	3.4e-06	4.35e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—IL2—lung cancer	3.4e-06	4.35e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—IL6—lung cancer	3.39e-06	4.33e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—IL6—lung cancer	3.38e-06	4.33e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—CREBBP—lung cancer	3.38e-06	4.32e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MTOR—lung cancer	3.38e-06	4.32e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PIK3CB—lung cancer	3.38e-06	4.32e-05	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—AKT1—lung cancer	3.37e-06	4.31e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—VEGFA—lung cancer	3.35e-06	4.29e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CASP3—lung cancer	3.34e-06	4.27e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—IL2—lung cancer	3.34e-06	4.27e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—VEGFA—lung cancer	3.33e-06	4.26e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—EP300—lung cancer	3.33e-06	4.25e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CCND1—lung cancer	3.32e-06	4.25e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—IL6—lung cancer	3.32e-06	4.24e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—STAT3—lung cancer	3.32e-06	4.24e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—JUN—lung cancer	3.31e-06	4.24e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CCND1—lung cancer	3.31e-06	4.24e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—NRAS—lung cancer	3.31e-06	4.23e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—JUN—lung cancer	3.31e-06	4.23e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—STAT3—lung cancer	3.3e-06	4.22e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—NRAS—lung cancer	3.29e-06	4.21e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GSTP1—lung cancer	3.29e-06	4.21e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—POMC—lung cancer	3.27e-06	4.18e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CCND1—lung cancer	3.25e-06	4.16e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—JUN—lung cancer	3.25e-06	4.15e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CXCL8—lung cancer	3.24e-06	4.15e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—PIK3CA—lung cancer	3.23e-06	4.13e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—MMP9—lung cancer	3.22e-06	4.12e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—HRAS—lung cancer	3.22e-06	4.12e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—MMP9—lung cancer	3.22e-06	4.11e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CDKN1A—lung cancer	3.21e-06	4.11e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CDKN1A—lung cancer	3.21e-06	4.1e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PTEN—lung cancer	3.21e-06	4.1e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PIK3CD—lung cancer	3.2e-06	4.09e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CAT—lung cancer	3.2e-06	4.09e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PTEN—lung cancer	3.2e-06	4.09e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PTEN—lung cancer	3.2e-06	4.09e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—CREBBP—lung cancer	3.18e-06	4.07e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—MAPK3—lung cancer	3.17e-06	4.05e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—ALB—lung cancer	3.16e-06	4.04e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—MMP9—lung cancer	3.16e-06	4.04e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—MAPK3—lung cancer	3.15e-06	4.03e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CDKN1A—lung cancer	3.15e-06	4.02e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PTEN—lung cancer	3.14e-06	4.01e-05	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—AKT1—lung cancer	3.13e-06	4.01e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—AKT1—lung cancer	3.13e-06	4e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—TP53—lung cancer	3.12e-06	3.99e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—AKT1—lung cancer	3.12e-06	3.99e-05	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—PIK3CA—lung cancer	3.12e-06	3.99e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—ABCB1—lung cancer	3.11e-06	3.98e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CASP3—lung cancer	3.1e-06	3.97e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IL2—lung cancer	3.1e-06	3.96e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—IL6—lung cancer	3.08e-06	3.94e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—MYC—lung cancer	3.08e-06	3.94e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—MYC—lung cancer	3.07e-06	3.92e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—AKT1—lung cancer	3.06e-06	3.92e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—TYMS—lung cancer	3.06e-06	3.91e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—EP300—lung cancer	3.06e-06	3.91e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—EP300—lung cancer	3.05e-06	3.9e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—EP300—lung cancer	3.05e-06	3.9e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GSTM1—lung cancer	3.02e-06	3.86e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CCND1—lung cancer	3.02e-06	3.86e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PIK3CD—lung cancer	3.02e-06	3.86e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—EGFR—lung cancer	3.02e-06	3.86e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—JUN—lung cancer	3.02e-06	3.86e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—EGFR—lung cancer	3e-06	3.84e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—EP300—lung cancer	2.99e-06	3.83e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—HRAS—lung cancer	2.99e-06	3.82e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—ALB—lung cancer	2.98e-06	3.81e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—SRC—lung cancer	2.97e-06	3.8e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—SRC—lung cancer	2.97e-06	3.79e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MMP9—lung cancer	2.93e-06	3.75e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CDKN1A—lung cancer	2.92e-06	3.74e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PTEN—lung cancer	2.92e-06	3.73e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—SRC—lung cancer	2.91e-06	3.72e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—VEGFA—lung cancer	2.9e-06	3.7e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—VEGFA—lung cancer	2.89e-06	3.69e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—STAT3—lung cancer	2.87e-06	3.67e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CYP1A1—lung cancer	2.87e-06	3.66e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—STAT3—lung cancer	2.86e-06	3.66e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—NRAS—lung cancer	2.86e-06	3.66e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—IL6—lung cancer	2.86e-06	3.65e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—NRAS—lung cancer	2.85e-06	3.65e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—KRAS—lung cancer	2.85e-06	3.64e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—AKT1—lung cancer	2.85e-06	3.64e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—ERCC2—lung cancer	2.84e-06	3.63e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—VEGFA—lung cancer	2.84e-06	3.63e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—KRAS—lung cancer	2.83e-06	3.62e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—STAT3—lung cancer	2.81e-06	3.59e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—NRAS—lung cancer	2.8e-06	3.58e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PIK3CB—lung cancer	2.79e-06	3.57e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—EP300—lung cancer	2.78e-06	3.56e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PTGS2—lung cancer	2.77e-06	3.54e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—MAPK3—lung cancer	2.74e-06	3.5e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—MAPK3—lung cancer	2.73e-06	3.49e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—SRC—lung cancer	2.7e-06	3.46e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—MAPK3—lung cancer	2.68e-06	3.43e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—MYC—lung cancer	2.66e-06	3.41e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—MYC—lung cancer	2.66e-06	3.4e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—AKT1—lung cancer	2.64e-06	3.37e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—VEGFA—lung cancer	2.63e-06	3.37e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PIK3CB—lung cancer	2.63e-06	3.36e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—PIK3CA—lung cancer	2.62e-06	3.35e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—MYC—lung cancer	2.61e-06	3.34e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—STAT3—lung cancer	2.61e-06	3.34e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PTGS2—lung cancer	2.61e-06	3.33e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—EGFR—lung cancer	2.61e-06	3.33e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—PIK3CA—lung cancer	2.6e-06	3.33e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—NRAS—lung cancer	2.6e-06	3.33e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—EGFR—lung cancer	2.6e-06	3.32e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—EGFR—lung cancer	2.55e-06	3.26e-05	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—AKT1—lung cancer	2.55e-06	3.26e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—TP53—lung cancer	2.53e-06	3.24e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—TP53—lung cancer	2.52e-06	3.22e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MAPK3—lung cancer	2.49e-06	3.19e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—KRAS—lung cancer	2.46e-06	3.15e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—PIK3CA—lung cancer	2.46e-06	3.15e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—APOA1—lung cancer	2.46e-06	3.14e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—KRAS—lung cancer	2.46e-06	3.14e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MYC—lung cancer	2.42e-06	3.1e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—HRAS—lung cancer	2.42e-06	3.1e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PTEN—lung cancer	2.41e-06	3.08e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—KRAS—lung cancer	2.41e-06	3.08e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—HRAS—lung cancer	2.41e-06	3.08e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—EGFR—lung cancer	2.37e-06	3.03e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—IL6—lung cancer	2.32e-06	2.96e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—IL6—lung cancer	2.31e-06	2.95e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—EP300—lung cancer	2.3e-06	2.94e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PTEN—lung cancer	2.27e-06	2.91e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PIK3CA—lung cancer	2.26e-06	2.89e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PIK3CA—lung cancer	2.26e-06	2.89e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PIK3CA—lung cancer	2.25e-06	2.88e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PIK3CG—lung cancer	2.24e-06	2.87e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—KRAS—lung cancer	2.24e-06	2.86e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PIK3CA—lung cancer	2.21e-06	2.83e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—TP53—lung cancer	2.19e-06	2.8e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—TP53—lung cancer	2.18e-06	2.79e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—EP300—lung cancer	2.17e-06	2.77e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—TP53—lung cancer	2.14e-06	2.74e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—AKT1—lung cancer	2.14e-06	2.73e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—POMC—lung cancer	2.14e-06	2.73e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—AKT1—lung cancer	2.13e-06	2.72e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—HRAS—lung cancer	2.09e-06	2.68e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—HRAS—lung cancer	2.09e-06	2.67e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CREBBP—lung cancer	2.08e-06	2.66e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PIK3CA—lung cancer	2.06e-06	2.63e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—HRAS—lung cancer	2.05e-06	2.62e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—AKT1—lung cancer	2.01e-06	2.57e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—IL6—lung cancer	2e-06	2.56e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—IL6—lung cancer	2e-06	2.56e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—TP53—lung cancer	1.99e-06	2.55e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PIK3CD—lung cancer	1.97e-06	2.52e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—IL6—lung cancer	1.96e-06	2.51e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—ALB—lung cancer	1.95e-06	2.49e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—HRAS—lung cancer	1.9e-06	2.43e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—AKT1—lung cancer	1.85e-06	2.36e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—AKT1—lung cancer	1.84e-06	2.36e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—AKT1—lung cancer	1.84e-06	2.36e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IL6—lung cancer	1.82e-06	2.33e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—AKT1—lung cancer	1.81e-06	2.31e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PIK3CB—lung cancer	1.72e-06	2.2e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PTGS2—lung cancer	1.7e-06	2.18e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PIK3CA—lung cancer	1.7e-06	2.18e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—AKT1—lung cancer	1.68e-06	2.15e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PIK3CA—lung cancer	1.6e-06	2.05e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PTEN—lung cancer	1.49e-06	1.9e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—EP300—lung cancer	1.42e-06	1.81e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—AKT1—lung cancer	1.39e-06	1.78e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—AKT1—lung cancer	1.31e-06	1.67e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PIK3CA—lung cancer	1.05e-06	1.34e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—AKT1—lung cancer	8.56e-07	1.09e-05	CbGpPWpGaD
